130 related articles for article (PubMed ID: 27347344)
1. RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level.
Kang L; Hao X; Tang Y; Wei X; Gong Y
Am J Transl Res; 2016; 8(5):2365-74. PubMed ID: 27347344
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
3. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
4. RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.
Zhang X; Min J; Wang Y; Li Y; Li H; Liu Q; Liang X; Mu P; Li H
J Exp Clin Cancer Res; 2013 Aug; 32(1):52. PubMed ID: 23941575
[TBL] [Abstract][Full Text] [Related]
5. Elevated RABEX-5 expression predicts poor prognosis in non-small-cell lung cancer.
Zhang F; Jia Y; Kong F; Hu G; Cai Q; Xu T
Am J Cancer Res; 2015; 5(9):2849-55. PubMed ID: 26609490
[TBL] [Abstract][Full Text] [Related]
6. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
Liu H; Liu Y; Kong F; Xin W; Li X; Liang H; Jia Y
J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
[TBL] [Abstract][Full Text] [Related]
7. Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.
Zhang F; Zhang M; Hu G; Cai Q; Xu T
Tumour Biol; 2015 Nov; 36(11):8287-93. PubMed ID: 26002576
[TBL] [Abstract][Full Text] [Related]
8. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
9. Higher RABEX-5 mRNA predicts unfavourable survival in patients with colorectal cancer.
Zhang JS; Yang LQ; Du BR; Gao H
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2372-2376. PubMed ID: 28617553
[TBL] [Abstract][Full Text] [Related]
10. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
11. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
12. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
[TBL] [Abstract][Full Text] [Related]
14. Elevated level of Vav1 was correlated with advanced biological behavior and poor prognosis in patients with gastric cancer.
Kang L; Hao X; Tang Y; Zhao Z; Zhang H; Gong Y
Int J Clin Exp Pathol; 2018; 11(1):391-398. PubMed ID: 31938123
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer.
He L; Chu D; Li X; Zheng J; Liu S; Li J; Zhao Q; Ji G
Dig Dis Sci; 2013 May; 58(5):1264-70. PubMed ID: 23314917
[TBL] [Abstract][Full Text] [Related]
16. Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer.
Ji F; Chen YL; Jin EY; Wang WL; Yang ZL; Li YM
World J Gastroenterol; 2005 Jun; 11(21):3222-6. PubMed ID: 15929171
[TBL] [Abstract][Full Text] [Related]
17. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
Ren J; Liu J; Sui X
J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of altered metallothionein 2A expression in gastric cancer according to Lauren's classification.
Pan YM; Xing R; Cui JT; Li WM; Lü YY
Chin Med J (Engl); 2013 Jul; 126(14):2681-6. PubMed ID: 23876896
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer.
Zhang SS; Wu LH; Liu Q; Chen KS; Zhang XF
Onco Targets Ther; 2015; 8():633-40. PubMed ID: 25792847
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.
Zhang JF; Zhang YP; Hao FY; Zhang CX; Li YJ; Ji XR
World J Gastroenterol; 2005 Sep; 11(36):5592-600. PubMed ID: 16237750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
